Lin-Jiu Wu, Xiao-Qing Liu: The ferroptosis-tumor microenvironment nexus: bidirectional regulation in cancer pathogenesis and therapeutic opportunities. Am J Cancer Res 2026;16(4):1247-1268. (Full text, PDF)
Liang Liao, Yunde Xu, Jindeng Liao, Xiaohui Liu, Jianwen Cheng, Jinmin Zhao: Targeting Osteoclastogenesis: Sabutoclax reduces tumor-associated osteolysis and tumor burden within the bone microenvironment. Am J Cancer Res 2026;16(4):1269-1288. (Full text, PDF)
Fanyan Wei, Yuxia Du, Haifeng Hu, Wenxia Li, Beiyu Tuo: Development and internal-external validation of a nomogram for predicting postoperative 30-day malnutrition risk in cervical cancer patients: a retrospective cohort study. Am J Cancer Res 2026;16(4):1289-1311. (Full text, PDF)
Qian Deng, Jianjun Jiang, Chuan Zhang, Lan Huang: Palliative radiotherapy plus multimodal analgesia for painful bone metastases: improved pain control and survival. Am J Cancer Res 2026;16(4):1312-1326. (Full text, PDF)
Zhenguo Zhao, Xinyu Li, Xinfeng Wang, Xu Liu, Jin Yuan, Xiaoyang Li, Luqiang Wang, Xinxin Zhang, Ting Liu, Shengji Yu: Development and temporal validation of a machine learning-based model to predict postoperative recurrence and guide adjuvant radiotherapy in patients with soft tissue sarcoma: a retrospective cohort study. Am J Cancer Res 2026;16(4):1327-1340. (Full text, PDF)
Wenting Liu, Rong Qiu, Manyun Liu, Genhua Huang: Establishment and verification of influencing factors and prediction model of early intestinal paralysis after radical operation of endometrial cancer. Am J Cancer Res 2026;16(4):1341-1353. (Full text, PDF)
Ching-Cheng Chang, Yi-Hsin Liang, Been-Ren Lin, Chi-Hung Wu, Kuo-Hsing Chen, Chia-Yu Yeh, Kun-Huei Yeh: Conversion-intent definitive liver-directed therapy improves survival in liver-predominant metastatic colorectal cancer. Am J Cancer Res 2026;16(4):1354-1366. (Full text, PDF)
Jiacheng Li, Shuo Sun, Yunzhe Jia, Qinzheng Bai: Clinical efficacy and safety of video-assisted thoracoscopic lobectomy versus wedge resection in elderly patients with early-stage non-small cell lung cancer. Am J Cancer Res 2026;16(4):1367-1380. (Full text, PDF)
Tolga Doğan, Semra Taş, Taliha Güçlü Kantar, Burçin Çakan Demirel, Havva Ören, Burcu Yapar Taşköylü, Atike Gökçen Demiray, Emre Hafızoğlu, Serkan Değirmencioğlu, Arzu Yaren, Gamze Gököz Doğu: Early host adaptation defined by nutritional and inflammatory dynamics predicts disease progression in solid tumours. Am J Cancer Res 2026;16(4):1381-1392. (Full text, PDF)
Juandi Liu, Yuan Hao, Ping Li, Miao Yuan, Miaoni Li, Ruiling Li: Multidimensional impact of venous thromboembolism on survival outcomes in ovarian cancer patients: deconstructing competing risks between thrombosis-related and tumor-related mortality. Am J Cancer Res 2026;16(4):1393-1414. (Full text, PDF)
Ping Lu, Ruyuan Guo, Guoli Zhao: Construction and external validation of a prognostic model for high-grade glioma based on IDH1 mutation status: implications for concurrent chemoradiotherapy efficacy. Am J Cancer Res 2026;16(4):1415-1436. (Full text, PDF)
Tianxiang Zhu, Yuting Liang, Wanyu Dong, Rushuang Deng, Wenshi Hu, Rong Wei, Qian Wang, Yaojuan Lu, Longwei Qiao, Tong-Chuan He, Qiping Zheng: COL10A1 beyond skeletal development: a hypertrophic chondrocyte-specific collagen emerging as a potential biomarker and tumor microenvironment regulator in solid cancers. Am J Cancer Res 2026;16(4):1437-1458. (Full text, PDF)
Da Miao, Jianjiang Liu, Bin Shen, Yujie Yang: Targeting ferroptosis in lung cancer: pharmacological regulation, nanomedicine-based delivery, and AI-enabled translational strategies. Am J Cancer Res 2026;16(4):1459-1483. (Full text, PDF)
Yi-Ru Lu, Chien-Ting Liu, Shih-Chung Wu, Chia-Che Wu, Shih-Yu Huang, Ching-Hua Tsai, Yen-Hao Chen: Low dose abemaciclib in heavily treated hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer. Am J Cancer Res 2026;16(4):1484-1494. (Full text, PDF)
Xuefeng Gu, Guoqing Wan, Yue Yang, Yihao Liu, Xintong Yang, Yanjun Zheng, Liying Jiang, Peng Zhang, Dingsheng Liu, Weiming Zhao, Gang Huang, Changlian Lu: SLFN5 influences proliferation and apoptosis by upregulating PTEN transcription via ZEB1 and inhibits the purine metabolic pathway in breast cancer: Am J Cancer Res. 2020; 10(9): 2832-2850. Am J Cancer Res 2026;16(4):1495-1496. (Full text, PDF)
Retraction: MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3. Am J Cancer Res 2026;16(4):1497. (Full text, PDF)
